Vimarsana
Biggest News Aggregation in the World

Banting Lecture News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Banting Lecture. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Banting Lecture Today - Breaking & Trending Today

In Memoriam: Robert S. Sherwin, MD, 1942-2023 - Vimarsana News

In Memoriam: Robert S. Sherwin, MD, 1942-2023

Dr. Sherwin was a world-renowned endocrinologist and diabetes researcher, a leader who oversaw the growth of clinical and translational research at Yale, and a

Source: yale.edu
Earlier Is Better: Treat Patients Before Type 2 Diabetes Develops - Vimarsana News

Earlier Is Better: Treat Patients Before Type 2 Diabetes Develops

Ralph DeFronzo, MD, discusses treating type 2 diabetes early and using drugs to correct the pathophysiologic disturbances associated with it.

Even heavyweights fall short: Tim Noakes on insulin resistance and Dr Reaven - Vimarsana News

Even heavyweights fall short: Tim Noakes on insulin resistance and Dr Reaven

Prof Tim Noakes look at how those who contributed extensively to the discovery of insulin resistance syndrome fell short.

Prof Reaven's 'Syndrome X' – Part 2 of Prof Noakes' series on insulin resistance - Vimarsana News

Prof Reaven's 'Syndrome X' – Part 2 of Prof Noakes' series on insulin resistance

Noakes takes the reader through Gerald M Reaven’s contribution to understanding insulin resistance syndrome or ‘Syndrome X’.

Merck: Glucophage Is the First Oral Diabetes Treatment Approved in Europe for Use During Pregnancy - Vimarsana News

Merck: Glucophage Is the First Oral Diabetes Treatment Approved in Europe for Use During Pregnancy

In a European worksharing procedure (WSP), Glucophage was approved as the first oral anti-diabetic medication to be used safely from conception to birth. The approval was granted on the